Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 5 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 11911434

    Stable antibody-drug conjugate, preparation method therefor, and use thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  2. US 11904010

    Recombinant virus capable of stably expressing target proteins

    BOEHRINGER INGELHEIM VETMEDICA (CHINA) CO., LTD. · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  3. US 11892530

    Magnetic resonance maps for analyzing tissue

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  4. US 11878011

    Method for eradicating Helicobacter pylori infection in patients regardless of body mass index

    RedHill Biopharma Ltd. · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  5. US 11872203

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  6. US 11872204

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  7. US 11865098

    Methods and compositions for treating excessive sleepiness

    AXSOME MALTA LTD. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  8. US 11865155

    Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof

    Botanic Century (Beijing) Co. Ltd. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  9. US 11858910

    Pyridinylmethylenepiperidine derivatives and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  10. US 11859016

    Peptide having cytoprotective effect against environmental pollutant and use thereof

    CAREGEN CO., LTD. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  11. US 11857528

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  12. US 11850227

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  13. US 11850228

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  14. US 11850226

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  15. US 11840525

    Use of AURKB small-molecule inhibitors for treatment of non-small cell lung cancer

    NANJING CHINA-AUSTRALIA INSTITUTE OF TRANSLATIONAL MEDICINE CO., LTD. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  16. US 11839599

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  17. US 11840575

    Engineered immune cells targeting BCMA and their uses thereof

    GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  18. US 11839598

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  19. US 11834413

    Antiplatelet drugs and uses thereof

    SHANGHAI CUREGENE PHARMACEUTICAL CO., LTD. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted
  20. US 11834688

    Ligase fusion proteins and application thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted
  21. US 11826392

    Purification method of fungal cell wall composition

    HONG SHENG PRECISION BIOTECH CO., LTD. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  22. US 11826432

    Linkers, conjugates and applications thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  23. US 11827687

    Synthetic somatostatin receptor ligands

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  24. US 11820833

    Peptides that inhibit binding of EPCR to its ligand to treat inflammation

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted